Please use this identifier to cite or link to this item: https://cir.cenieh.es/handle/20.500.12136/2614
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartinón-Torres, Federico-
dc.contributor.authorGarcía-Sastre, Adolfo-
dc.contributor.authorPollard, Andrew J.-
dc.contributor.authorMartín, Carlos-
dc.contributor.authorOsterhaus, Albert-
dc.contributor.authorLadhani, Shamez N.-
dc.contributor.authorRamilo, Octavio-
dc.contributor.authorGómez Rial, Jose-
dc.contributor.authorSalas, Antonio-
dc.contributor.authorBosch, F. Xavier-
dc.contributor.authorMartinón-Torres, María-
dc.contributor.authorMina, Michael J.-
dc.contributor.authorCherry, James-
dc.date.accessioned2022-04-07T12:23:39Z-
dc.date.issued2021-11-
dc.identifier.citationHuman Vaccines & Immunotherapeutics, 17:11, 4299-4327es_ES
dc.identifier.issn2164-5515-
dc.identifier.issn2164-554X-
dc.identifier.urihttp://cir.cenieh.es/handle/20.500.12136/2614-
dc.description.abstractTIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts.es_ES
dc.description.sponsorshipFM-T receives support for research activities from the Instituto de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud): Fondo de Investigacion Sanitaria (FIS; PI070069/PI1000540/ PI1601569/PI1901090) del plan nacional de I+D+I and ‘fondos FEDER’ and Proyectos GaIN Rescata-Covid_IN845D 2020/23 (GAIN, Xunta de Galicia).es_ES
dc.language.isoenes_ES
dc.publisherTaylor and Francis Ltd.es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectInfectious diseasees_ES
dc.subjectvaccinepreventable diseasees_ES
dc.subjectCOVID- 19 pandemices_ES
dc.subjectcontrol of transmissiones_ES
dc.subjectvaccineimmunity responsees_ES
dc.subjectsevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2)es_ES
dc.titleTIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO)es_ES
dc.typeArticlees_ES
dc.identifier.doi10.1080/21645515.2021.1953351-
dc.relation.publisherversionhttps://doi.org/10.1080/21645515.2021.1953351-
dc.date.available2022-04-07T12:23:39Z-
Appears in Collections:Paleobiología



This item is licensed under a Creative Commons License Creative Commons